Total Payments
$5,198
2024 Payments
$1,713
Companies
29
Transactions
212
Medicare Patients
1,066
Medicare Billing
$134,334
Payment Breakdown by Category
Food & Beverage$5,088 (97.9%)
Education$110.58 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,088 | 210 | 97.9% |
| Education | $110.58 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $997.44 | 36 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $523.23 | 34 | $0 (2024) |
| Gilead Sciences, Inc. | $502.41 | 11 | $0 (2024) |
| Celgene Corporation | $325.53 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $286.52 | 9 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $274.69 | 14 | $0 (2024) |
| QOL Medical, LLC | $268.68 | 12 | $0 (2024) |
| PFIZER INC. | $236.32 | 11 | $0 (2024) |
| GENZYME CORPORATION | $227.00 | 6 | $0 (2024) |
| NuVasive, Inc. | $178.75 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,713 | 76 | ABBVIE INC. ($379.56) |
| 2023 | $2,213 | 100 | AbbVie Inc. ($462.38) |
| 2022 | $916.98 | 33 | ABBVIE INC. ($155.50) |
| 2019 | $262.08 | 2 | NuVasive, Inc. ($178.75) |
| 2017 | $93.95 | 1 | Janssen Biotech, Inc. ($93.95) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $10.56 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/06/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $3.11 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: LIVER DISEASE | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.95 | General |
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Immunology | ||||||
| 09/20/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $30.32 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/17/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Immunology | ||||||
| 09/12/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/28/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $26.54 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.04 | General |
| 08/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.34 | General |
| Category: GI | ||||||
| 08/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/01/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $9.07 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 318 | 365 | $143,179 | $43,314 |
| 2022 | 6 | 162 | 166 | $119,787 | $17,430 |
| 2021 | 11 | 347 | 356 | $250,299 | $46,858 |
| 2020 | 8 | 239 | 249 | $177,682 | $26,733 |
Total Patients
1,066
Total Services
1,136
Medicare Billing
$134,334
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 47 | 49 | $26,950 | $11,316 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $30,855 | $11,261 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 101 | $27,977 | $11,246 | 40.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 39 | $21,450 | $2,746 | 12.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 13 | $5,083 | $2,042 | 40.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 38 | 42 | $23,100 | $1,962 | 8.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $4,334 | $1,680 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,430 | $1,060 | 30.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 32 | 32 | $36,556 | $6,331 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $17,447 | $5,213 | 29.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 30 | 30 | $33,084 | $1,850 | 5.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 23 | $6,351 | $1,801 | 28.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 26 | $23,348 | $1,687 | 7.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $3,001 | $547.14 | 18.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 66 | 67 | $33,193 | $11,743 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 54 | 54 | $22,454 | $7,737 | 34.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 35 | 36 | $45,957 | $7,683 | 16.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 47 | 50 | $52,008 | $4,226 | 8.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 28 | $9,338 | $3,175 | 34.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 36 | 37 | $45,917 | $3,153 | 6.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 18 | $4,905 | $2,043 | 41.7% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 21 | 21 | $16,992 | $1,988 | 11.7% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 11 | 11 | $10,507 | $1,875 | 17.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $5,237 | $1,852 | 35.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 15 | $3,792 | $1,383 | 36.5% |
About Dr. Dabo Xu, MD
Dr. Dabo Xu, MD is a Internal Medicine healthcare provider based in Leesburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2013. The National Provider Identifier (NPI) number assigned to this provider is 1649616301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dabo Xu, MD has received a total of $5,198 in payments from pharmaceutical and medical device companies, with $1,713 received in 2024. These payments were reported across 212 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,088).
As a Medicare-enrolled provider, Xu has provided services to 1,066 Medicare beneficiaries, totaling 1,136 services with total Medicare billing of $134,334. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Gastroenterology
- Location Leesburg, VA
- Active Since 05/21/2013
- Last Updated 04/01/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649616301
Products in Payments
- ZEPOSIA (Drug) $452.40
- XIFAXAN (Drug) $407.53
- Vemlidy (Drug) $345.61
- LINZESS (Drug) $338.93
- DUPIXENT (Biological) $315.10
- SKYRIZI (Biological) $274.95
- OCALIVA (Drug) $274.69
- XELJANZ (Drug) $236.32
- CREON (Drug) $232.91
- SUCRAID (Drug) $185.61
- Pulse (Device) $178.75
- STELARA (Biological) $173.17
- REMICADE (Biological) $172.97
- ENTYVIO (Biological) $164.87
- IBSRELA (Drug) $160.68
- DIFICID (Drug) $118.01
- Linzess (Drug) $115.92
- TRULANCE (Drug) $115.70
- Sucraid (Drug) $83.07
- Leqembi (Drug) $82.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Leesburg
Dr. David Lichtinger, D.o, D.O
Internal Medicine — Payments: $17,918
Internal Medicine $17,918
Jahanbakhsh Naghshin, M.d, M.D
Internal Medicine — Payments: $13,133
Internal Medicine $13,133
Sheyla Zelaya-Aragon
Internal Medicine — Payments: $11,938
Internal Medicine $11,938
Diane Traficante, Do, DO
Internal Medicine — Payments: $9,193
Internal Medicine $9,193
Dr. Ravi Gupta, M.d, M.D
Internal Medicine — Payments: $8,000
Internal Medicine $8,000
Dr. Sepehr Mesdaghinia, M.d, M.D
Internal Medicine — Payments: $6,588
Internal Medicine $6,588